Following the LGS, we observed a reduction of the circulating inflammatory mediators and cytokines of TNF-alpha, IL-6, MCP-1, and hsCRP, which match the significant weight loss observed. This evidence concerns the gene CCL2 and Lennox-Gastaut syndrome.